Cargando…

Uncover diagnostic immunity/hypoxia/ferroptosis/epithelial mesenchymal transformation-related CCR5, CD86, CD8A, ITGAM, and PTPRC in kidney transplantation patients with allograft rejection

The aim of this study was to identify predictive immunity/hypoxia/ferroptosis/epithelial mesenchymal transformation (EMT)-related biomarkers, pathways and new drugs in allograft rejection in kidney transplant patients. First, gene expression data were downloaded followed by identification of differe...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Long, Wang, Boqian, Wang, Xueyi, Liu, Yuewen, Song, Xing, Zhang, Yijian, Li, Xin, Yang, Hongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639483/
https://www.ncbi.nlm.nih.gov/pubmed/36330810
http://dx.doi.org/10.1080/0886022X.2022.2141648
_version_ 1784825651034849280
author He, Long
Wang, Boqian
Wang, Xueyi
Liu, Yuewen
Song, Xing
Zhang, Yijian
Li, Xin
Yang, Hongwei
author_facet He, Long
Wang, Boqian
Wang, Xueyi
Liu, Yuewen
Song, Xing
Zhang, Yijian
Li, Xin
Yang, Hongwei
author_sort He, Long
collection PubMed
description The aim of this study was to identify predictive immunity/hypoxia/ferroptosis/epithelial mesenchymal transformation (EMT)-related biomarkers, pathways and new drugs in allograft rejection in kidney transplant patients. First, gene expression data were downloaded followed by identification of differentially expressed genes (DEGs), weighted gene co-expression network analysis (WGCNA) and protein–protein interaction (PPI) analysis. Second, diagnostic model was construction based on key genes, followed by correlation analysis between immune/hypoxia/ferroptosis/EMT and key diagnostic genes. Finally, drug prediction of diagnostic key genes was carried out. Five diagnostic genes were further identified, including CCR5, CD86, CD8A, ITGAM, and PTPRC, which were positively correlated with allograft rejection after the kidney transplant. Highly infiltrated immune cells, highly expression of hypoxia-related genes and activated status of EMT were significantly positively correlated with five diagnostic genes. Interestingly, suppressors of ferroptosis (SOFs) and drivers of ferroptosis (DOFs) showed a complex regulatory relationship between ferroptosis and five diagnostic genes. CD86, CCR5, and ITGAM were respectively drug target of ABATACEPT, MARAVIROC, and CLARITHROMYCIN. PTPRC was drug target of both PREDNISONE and EPOETIN BETA. In conclusion, the study could be useful in understanding changes in the microenvironment within transplantation, which may promote or sustain the development of allograft rejection after kidney transplantation.
format Online
Article
Text
id pubmed-9639483
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-96394832022-11-08 Uncover diagnostic immunity/hypoxia/ferroptosis/epithelial mesenchymal transformation-related CCR5, CD86, CD8A, ITGAM, and PTPRC in kidney transplantation patients with allograft rejection He, Long Wang, Boqian Wang, Xueyi Liu, Yuewen Song, Xing Zhang, Yijian Li, Xin Yang, Hongwei Ren Fail Clinical Study The aim of this study was to identify predictive immunity/hypoxia/ferroptosis/epithelial mesenchymal transformation (EMT)-related biomarkers, pathways and new drugs in allograft rejection in kidney transplant patients. First, gene expression data were downloaded followed by identification of differentially expressed genes (DEGs), weighted gene co-expression network analysis (WGCNA) and protein–protein interaction (PPI) analysis. Second, diagnostic model was construction based on key genes, followed by correlation analysis between immune/hypoxia/ferroptosis/EMT and key diagnostic genes. Finally, drug prediction of diagnostic key genes was carried out. Five diagnostic genes were further identified, including CCR5, CD86, CD8A, ITGAM, and PTPRC, which were positively correlated with allograft rejection after the kidney transplant. Highly infiltrated immune cells, highly expression of hypoxia-related genes and activated status of EMT were significantly positively correlated with five diagnostic genes. Interestingly, suppressors of ferroptosis (SOFs) and drivers of ferroptosis (DOFs) showed a complex regulatory relationship between ferroptosis and five diagnostic genes. CD86, CCR5, and ITGAM were respectively drug target of ABATACEPT, MARAVIROC, and CLARITHROMYCIN. PTPRC was drug target of both PREDNISONE and EPOETIN BETA. In conclusion, the study could be useful in understanding changes in the microenvironment within transplantation, which may promote or sustain the development of allograft rejection after kidney transplantation. Taylor & Francis 2022-11-04 /pmc/articles/PMC9639483/ /pubmed/36330810 http://dx.doi.org/10.1080/0886022X.2022.2141648 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
He, Long
Wang, Boqian
Wang, Xueyi
Liu, Yuewen
Song, Xing
Zhang, Yijian
Li, Xin
Yang, Hongwei
Uncover diagnostic immunity/hypoxia/ferroptosis/epithelial mesenchymal transformation-related CCR5, CD86, CD8A, ITGAM, and PTPRC in kidney transplantation patients with allograft rejection
title Uncover diagnostic immunity/hypoxia/ferroptosis/epithelial mesenchymal transformation-related CCR5, CD86, CD8A, ITGAM, and PTPRC in kidney transplantation patients with allograft rejection
title_full Uncover diagnostic immunity/hypoxia/ferroptosis/epithelial mesenchymal transformation-related CCR5, CD86, CD8A, ITGAM, and PTPRC in kidney transplantation patients with allograft rejection
title_fullStr Uncover diagnostic immunity/hypoxia/ferroptosis/epithelial mesenchymal transformation-related CCR5, CD86, CD8A, ITGAM, and PTPRC in kidney transplantation patients with allograft rejection
title_full_unstemmed Uncover diagnostic immunity/hypoxia/ferroptosis/epithelial mesenchymal transformation-related CCR5, CD86, CD8A, ITGAM, and PTPRC in kidney transplantation patients with allograft rejection
title_short Uncover diagnostic immunity/hypoxia/ferroptosis/epithelial mesenchymal transformation-related CCR5, CD86, CD8A, ITGAM, and PTPRC in kidney transplantation patients with allograft rejection
title_sort uncover diagnostic immunity/hypoxia/ferroptosis/epithelial mesenchymal transformation-related ccr5, cd86, cd8a, itgam, and ptprc in kidney transplantation patients with allograft rejection
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639483/
https://www.ncbi.nlm.nih.gov/pubmed/36330810
http://dx.doi.org/10.1080/0886022X.2022.2141648
work_keys_str_mv AT helong uncoverdiagnosticimmunityhypoxiaferroptosisepithelialmesenchymaltransformationrelatedccr5cd86cd8aitgamandptprcinkidneytransplantationpatientswithallograftrejection
AT wangboqian uncoverdiagnosticimmunityhypoxiaferroptosisepithelialmesenchymaltransformationrelatedccr5cd86cd8aitgamandptprcinkidneytransplantationpatientswithallograftrejection
AT wangxueyi uncoverdiagnosticimmunityhypoxiaferroptosisepithelialmesenchymaltransformationrelatedccr5cd86cd8aitgamandptprcinkidneytransplantationpatientswithallograftrejection
AT liuyuewen uncoverdiagnosticimmunityhypoxiaferroptosisepithelialmesenchymaltransformationrelatedccr5cd86cd8aitgamandptprcinkidneytransplantationpatientswithallograftrejection
AT songxing uncoverdiagnosticimmunityhypoxiaferroptosisepithelialmesenchymaltransformationrelatedccr5cd86cd8aitgamandptprcinkidneytransplantationpatientswithallograftrejection
AT zhangyijian uncoverdiagnosticimmunityhypoxiaferroptosisepithelialmesenchymaltransformationrelatedccr5cd86cd8aitgamandptprcinkidneytransplantationpatientswithallograftrejection
AT lixin uncoverdiagnosticimmunityhypoxiaferroptosisepithelialmesenchymaltransformationrelatedccr5cd86cd8aitgamandptprcinkidneytransplantationpatientswithallograftrejection
AT yanghongwei uncoverdiagnosticimmunityhypoxiaferroptosisepithelialmesenchymaltransformationrelatedccr5cd86cd8aitgamandptprcinkidneytransplantationpatientswithallograftrejection